Top Markets
Coin of the day
Gentian Diagnostics AS Gentian Diagnostics AS

Gentian Diagnostics AS

GENT
Clasificación en acciones #24261
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents... Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay test kit, a particle-enhanced turbidimetric immunoassay for quantitative determination of canine C-reactive protein in dog plasma and serum. The company also develops faecal calprotectin immunoassay turbo that offers results of calprotectin concentration in stool supporting diagnosis of inflammatory bowel disease; and faecal pancreatic elastase immunoassay turbo, which allows analysis of pancreatic elastase in stool to aid in diagnosis of pancreatic exocrine insufficiency. Gentian Diagnostics ASA was founded in 2001 and is headquartered in Moss, Norway.
Precio por acción
$4.07
Última sincronización: 2026-08-21
Capitalización bursátil
$62.87M
Cambio (1 día)
3.19%
Cambio (1 año)
-28.25%
País
NO
Comercio Gentian Diagnostics AS (GENT)

Categoría

Ratio P/B de Gentian Diagnostics AS (GENT)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Gentian Diagnostics AS, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Gentian Diagnostics AS desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras